Human postmortem digital arteries obtained between 6 and 60 hours after death were used for in vitro studies of vascular smooth muscle physiology and pharmacology. Isometric tension was recorded from spiral strips in tissue baths at 37°C. The responses were durable and reproducible and were similar to those of 10 operative specimens of visceral arteries. The contractile force of the preparations was unrelated to the time elapsed since death. Norepinephrine, 5-hydroxytryptamine, and barium chloride gave the strongest responses; histamlne and potassium chloride were weaker agonists. Hie order of sensitivities to the agonists tested was angiotensin > 5hydroxytryptamine > norepinephrine > histamlne > barium chloride > potassium chloride. Both competitive (phentolamlne) and noncompetitive (phenoxybenzamlne) antagonism of DorepiDephrine was demonstrated. Pbentolamine was also a weak inhibitor of 5-hydroxytryptamine. Cyprobeptadine was a potent antagonist of 5-hydroxytryptamine, but had less effect against norepinephrine. This suggests the presence of separate receptors for 5hydroxytryptamine and norepinephrine in these vessels. The response to barium chloride was inhibited by the calcium-antagonist, verapamil. The o-adrenoceptor antagonist, phentolamlne, was not effective against barium chloride. We conclude that human postmortem digital arteries can be studied effectively in vitro. The preparation should be useful for the evaluation of drugs that are thought to act at a peripberal vascular site.
MANY clinically used hypotensive agents produce their pharmacological effect by either a direct or an indirect action on arterial smooth muscle. 1 Studies on their mechanism of action have been limited to in vivo experiments in human subjects or animals, which allow only limited manipulation of environmental variables, or to in vitro experiments in animals, in which there may be problems with species specificity. 2 Therefore, an in vitro preparation for humans would be of great potential value, both for studying the physiology and pharmacology of human vascular smooth muscle and for elucidating the mechanisms of drug action at this peripheral site. This paper describes such a preparation and its responses to various pharmacological agonists and antagonists.
Methods
The artery selected for study was the palmar common digital artery to the 2nd and 3rd fingers, which was obtained at autopsy between 6 and 60 hours after death. A record was kept of the personal details of each patient from whom an artery was removed, including past history, cause of death, and medical treatment. None of these factors seemed to influence the in vitro responses of the arterial smooth muscle. The vessel was dissected from its origin at the superficial palmar arch to the base of the finger. For comparative studies, 10 operative specimens of branches of uterine, ovarian, ileocolic, and splenic arteries were obtained at surgery. The specimens were obtained in accordance with the rules governing research performed on tissues from human subjects in the Royal Melbourne Hospital.
A fine wire was threaded down the lumen of the artery, which was carefully dissected free of all connective tissue and made into a helical strip by cutting the wall at an approximate 45-degree angle to the longitudinal axis of the vessel. Due to interindividual variations in the caliber of the vessels, the width of the strips varied between 1 and 3 mm, and they were usually about 15 mm long. The spiral strip was often long enough for more than one segment to be prepared, and, in the course of this study, more than 70 segments from over 40 different arteries were used. The strips were tied at each end with black linen thread, connected to small metal rings, and suspended in a 30-ml tissue bath at 37°C. The bath fluid had the following composition (ITIM): Na + , 137.4; K + , 5.4; Ca 2+ , 2.5; Mg 2+ , 1.2; Cl", 131.5; SO, 2 ", 1.2; H 2 POT, 1.2; HCO,", 15.0; glucose, 11.5. For experiments with barium chloride, SO 4 2~ was omitted from the bath fluid to avoid salt precipitation. Oxygen containing 5% carbon dioxide was gassed through the solution which then had a pH between 7.2 and 7.4. Isometric tension was measured with either a Grass FTO3C or a Hewlett Packard FTA 100-1 transducer and a Hewlett Packard 7758A or 7702B recorder. The initial resting tension was adjusted to about 2 g, and the artery was left to relax for about 1 hour. If necessary, the resting tension was readjusted until a baseline level greater than 1 g was obtained. The response to the addition of KG, 80 mM, then was tested, and this contracture was used as the standard reference contracture for that particular artery.
Drugs used were norepinephrine (L-arterenol bitartrate, Sigma; or Levophed, Winthrop), 5-hydroxytryptamine (5-HT) creatinine sulfate (Sigma), angiotensin amide (Hypertensin, Ciba), histamine dihydrochloride (Sigma), phentolamine mesylate (Regitine, Ciba), phenoxybenza- VOL. 42, No. 3, MARCH 1978 mine hydrochloride (Dibenyline, Smith, Kline and French), cyproheptadine hydrochloride (Merck, Sharp and Dohme), barium chloride (British Drug Houses), and verapamil hydrochloride (Isoptin, Knoll). Dilutions of 5-HT and phentolamine were prepared every few days; other drugs, daily. Norepinephrine was diluted in ascorbic acid, lO"* M; other drugs were diluted in distilled H 2 O.
Drug effects were studied by performing cumulative agonist dose-response curves. Antagonists were added to the bath in increasing order of concentration. pA2 values were calculated according to the method of Schild. 3 The data were statistically analyzed by Student's r-test and Spearman's p measure of correlation.
Results

General Characterization of the Preparation
Preliminary Studies on in Vitro Durability
In a preliminary series of experiments, the durability and reproducibility of the responses obtained from six arterial segments over the estimated duration of one experiment was tested. Repeated contractures were elicited by KC1, 80 mM. This concentration gave the maximum response to KC1. After approximately 1 hour of relaxation and equilibration in the tissue bath, the force developed on exposure to KC1 increased steadily over approximately 2 hours. When the response appeared to have reached its maximum, the height of the KC1 contracture was taken as the standard to be used, and a norepinephrine dose-response curve was performed ( Fig. 1 ). The arteries then were left in the tissue bath until the end of the day. Then, usually more than 6 hours after the arteries had been first mounted in the bath, the responses to KC1 and norepinephrine were tested again. They were reproducible in strength: the force at the start of the six experiments was 1.78 ± 0.45 g (mean ± SE); that at 6 hours was 1.84 ± 0.45 g (P > 0.5). The sensitivity to norepinephrine also was unchanged: initially, the maximum response was 3.18 ± 0.59 g; at 6 hours it was 3.28 ± 0.67 g (P > 0.5). Three preparations were left in the bath for 24 hours and still gave the same reproducible contractures.
The Influence of Postmortem Body Storage
Since the arteries were obtained at autopsy at variable times after death, a possible postmortem deterioration of the contractile responses of the arteries had to be excluded. First, the force developed by the postmortem specimens on exposure to KG, 80 min, was plotted against the time of cold body storage ( Fig. 2) . When more than one arterial segment from the same body was studied, only the strongest response is shown. A wide scatter was found in the contractile force developed by the arteries studied, which is probably explained by interdividual anatomical variations in the sizes of the arteries. However, there was no statistically significant correlation between the two variables (P > 0.1; the estimate of Spearman's correlation coefficient wasr,= 0.0953, where 0 stands for no correlation and 1.0 for perfect correlation). Second, 10 visceral arteries of comparable caliber obtained during abdominal surgery were studied and their There is thus neither a correlation between the time of storage after death and the contractile force developed by the postmortem arteries, nor a difference between the responses of postmortem and operative specimens. The arterial smooth muscle of the digital artery, therefore, appears to retain its contractile potency under the conditions of cold-body storage over the observed period of time.
Tachyphylaxis to Vasoconstrictor Agents
The susceptibility of the arteries to tachyphylaxis to each of the agonists to be used was tested by performing repeated dose-response curves with the agonist on the same arterial segment. It was found that no tachyphylaxis occurred as an effect of KC1, and only a small degree of tachyphylaxis occurred to the effects of norepinephrine, 5-HT, or BaClj. However, in a manner similar to that reported for many animal arterial preparations, marked tachyphylaxis occurred to the effects of angiotensin . 4 
-5
Responses to Various Agonists
To characterize the responsiveness of small systemic human arteries to pressor substances, we compared the responses to a group of agonists which are thought to either stimulate vascular smooth muscle through specific receptors or activate the contractile mechanism through a different pathway ( Fig. 3) . Angiotensin, 5-HT, and norepinephrine were effective at much lower molar concentrations than the other agonists tested. The responses to norepinephrine and 5-HT were very similar. The agonist concentrations required for the threshold response, as well as the maximum response, were not significantly different, and a comparable maximum tension was developed in each case. However, the threshold response to angiotensin occurred at somewhat lower molar concentrations, whereas the maximum tension developed was significantly less than that on exposure to norepinephrine and 5-HT.
The contractile response of the arteries to histamine was quite different from the responses to the more potent agonists. The threshold response to histamine occurred at 100 times greater concentration; the slope of the doseresponse curves was more shallow, and the maximum tension developed was considerably less than that produced by 5-HT and norepinephrine. Also, the arteries contracted much more rapidly on exposure to histamine than to any other agonist. The responses to potassium and barium chloride occurred at much higher concentrations than those produced by the agonists, which are thought to act through receptors.
Effects of Antagonists
Smooth muscle contraction can be antagonized at different steps in the sequence of events contributing to the excitation-contraction mechanism. Some antagonists exert their action at the level of the specific receptor.*" 8 Antagonists of the excitation-contraction coupling activity of calcium ions interfere with a more distal step in that series of events and inhibit all contractile responses, whether or not they are normally mediated by specific receptors. 9 Both forms of antagonism were demonstrated in this preparation.
Antagonism at the Receptor Level
We selected norepinephrine, phenoxybenzamine, and phentolamine to demonstrate different types of antagonism at the a-receptor site.
Phenoxybenzamine is thought to inactivate the a-receptor irreversibly by forming covalent bonds with its site of action. The resulting nature of inhibition is therefore a noncompetitive one. Phenoxybenzamine antagonized the effects of norepinephrine by producing dose-dependent, nonparallel shifts of the norepinephrine dose-response curves and reducing the overall maximum response (Fig.  4A) .
Phentolamine, a competitive a-adrenoceptor antagonist, caused parallel, dose-dependent shifts of the norepinephrine dose-response curves without reducing the maximum response (Fig. 4B ). The mean pA 2 value for the affinity of phentolamine for the a-receptor was 7.76 ± 0.11 (SEM) (n = 7), a value similar to those obtained by other investigators in animal tissues. 7 ' 10 Receptor antagonism studies also can be used to differentiate between specific receptors for different agonists. 6 ' 7 We therefore compared the effects of phentol- Phentolamine antagonized contractions produced by 5-HT in a competitive manner. With its relative specificity for the a-adrenergic receptor, however, it was a less potent inhibitor of 5-HT than of norepinephrine, with a mean pA 2 value of 6.93 ± 0.21 (n = 8). This was significantly different (P < 0.005) from its potency against norepinephrine and suggests that the effects of norepinephrine and 5-HT were mediated through different receptors.
Cyproheptadine was a much more potent antagonist of 5-HT than of norepinephrine. In the presence of three concentrations of cyproheptadine, the norepinephrine dose-response curves were shifted to the right in a competitive manner (Fig. 5A) , yielding a mean pA 2 value of 7.41 ± 0.06 (n = 5). The response to 5-HT in the presence of the same doses of cyproheptadine was variable, in some experiments resembling a competitive, in others a noncompetitive, type of antagonism. Therefore a direct comparison of pA 2 values could not be made. However, the shift in the 5-HT dose-response curves (Fig. 5B ) was much greater than in the norepinephrine dose-response curves (Fig. 5A ). This is consistent with the presence of different populations of receptors for 5-HT and norepinephrine in this preparation.
Calcium Antagonism
Phentolamine, which antagonizes smooth muscle contraction at the level of the a-receptor, would not be expected to interfere with more distal steps of the excitation-contraction mechanism. Therefore, the effects of phentolamine were tested on contractures produced by barium chloride, which can substitute for calcium under in vitro conditions." Figure 6A shows that the concentrations that were effective at the receptor level had no effect on the barium dose-response curves; thus, phentolamine does not interfere with the actions of calcium ions in the contractile mechanism of vascular smooth muscle. However, these actions were antagonized by the calcium antagonist, verapamil, which has been shown to inhibit the excitation-contraction coupling mechanism in mammalian myocardial and smooth muscle fibers." In this preparation, verapamil caused a dose-dependent, parallel shift of the barium dose-response curves (Fig. 6B) . At BaCIj > 10~2 M, responses developed very slowly, and the dose-response curves could not be followed to their true maximum. However, from the dose-response curves obtained at BaCl 2 < 10" 2 M, the parallel slope and shift of the curves at increasing concentrations of verapamil suggest a competitive rather than a noncompetitive mechanism of inhibition.
Discussion
Any isolated preparation must fulfill at least two criteria to provide relevant results. First, it must be durable in vitro and function reproducibly for at least several hours. In the preparation described here, durability and reproducibility were demonstrated by repeated exposure to KC1 and norepinephrine.
Second, the preparation must function similarly in vitro and in vivo. When postmortem human tissues are studied, whether they function the same in vitro as they do in vivo may be determined by the period of body storage before tissues can be removed. We found no significant correlation between the time of cold-body storage and the responsiveness of the arterial smooth muscle in vitro. The responses also were not different from those obtained with operative specimens of visceral arteries. Therefore, it seems that the tissue is functioning the same in vitro as it does in vivo.
Tachyphylaxis is considered to be an intrinsic property of the individual tissue receptors, and is known to occur in vivo as well as in vitro. It is not usually considered to be an indication of general deterioration of a tissue in vitro. The small amount of tachyphylaxis that occurred on repeated exposure to norepinephrine, 5-HT, and BaCl 2 was negligible. Neither the viability nor the value of the preparation is negated by such a degree of tachyphylaxis.
The results we have obtained by studying the effects of various agonists and antagonists are of sufficient interest to be considered, each in turn. Norepinephrine, the physiological vascular smooth muscle stimulant, would have been expected to be effective at the low concentrations that produced contractile responses, and the responses of this preparation are similar to those of standard animal preparations. The effects of phenoxybenzamine and phentolamine were also consistent with their wellestablished pharmacological properties' 2 -" and confirm the integrity of the a-adrenergic receptor.
The inverse specificity profiles of phentolamine and cyproheptadine in the antagonist crossover studies with norepinephrine and 5-HT suggest that specific 5-HT receptors are present in this preparation. This probably explains the finding that 5-HT was a more potent agonist than might have been expected and obviously suggests a possible role for 5-HT in the maintenance of human vascular smooth muscle tone. This suggestion is supported by the findings of other investigators, who have found considerable amounts of 5-HT in the arterial wall. 14 The concentrations they have measured are comparable to those which we have shown produce arterial contractures. Since some standard animal preparations, such as the rabbit ear artery, appear not to contain any specific 5-HT receptors, 7 the preparation described here is more suitable for the investigation of any human peripheral vascular responses which may involve the participation of 5-HT receptors.
Similarly, the high sensitivity of the preparations to angiotensin would suggest a possible physiological role for that agent in the maintenance of arterial smooth muscle tone. The different shape of the angiotensin doseresponse curve from those for norepinephrine or 5-HT suggests that the responses to angiotensin are also mediated through different receptors. The occurrence of marked tachyphylaxis to the effects of angiotensin, an observation well documented in animal tissues," would have made formal receptor differentiation studies with different antagonists very difficult, and they were not performed.
Contractile responses to histamine have been described in many animal arterial preparations.' 6 " 17 However, a physiological role of this amine in the maintenance of arterial smooth muscle tone seems unlikely. Accordingly, the contractile responses to histamine in this preparation occurred at concentrations much higher than would be expected for a physiologically relevant pressor agent.
Barium ions, which can substitute in vitro for calcium in the excitation-contraction coupling mechanism, are effective at lower concentrations than calcium. The range of concentrations, however, is limited. At BaCl 2 > 10~2 M, contractures developed extremely slowly. This observation was independent of the concentration of verapamil. Occasional segments which were less sensitive to BaCl 2 and required higher agonist concentrations to reach the maximum response, even in the absence of verapamil, gave very slow responses at more than 10~2 M BaCl 2 . Apparently, an inhibiting factor different from the drug to be tested impeded the contractile responses at these high concentrations of BaCl 2 . Since excessive concentrations of chloride ions have been shown to alter membrane permeability for calcium ions in skeletal muscle," 1 this might possibly be the limiting factor in smooth muscle contracturc produced by BaCl 2 . Despite this limitation, however, the practical range of BaCl 2 concentrations still permits antagonism studies to be performed to differentiate between antagonists at the receptor level (e.g., phentolamine) and antagonists of the more distal steps of the contractile process which are mediated by calcium ions.' 9 These results show that human arterial smooth muscle preparations can be studied effectively in vitro. Differences between human and animal vascular responses indicate species-specific tissue properties and therefore make human tissue responses more relevant for studying the physiology and pharmacology of human vasculature. The use of this preparation is suggested for evaluation of drugs which, from standard pharmacological investigations, are thought to act at a peripheral vascular site. 
SUMMARY Previous reports by several investigators on the activation of a high molecular weight renin have not been confirmed.
A simple method of extracting hog kidneys by using toluene was modified to yield partially purified renin with a molecular weight of 60,000, exclusively. Attempts to increase the activity of this renin by acidification resulted in a loss of 20-90% of the total activity, although the renin activity remaining was converted to a molecular weight of 40,000 and its specific activity increased 10-fold over that of the original. Attempts to obtain increased activity of the 60,000 molecular weight renin by adding crude kidney extract before the acidification did not result in activation. Activity of renin partially purified by a procedure involving acidification was inhibited by the addition of crude kidney extract. Incubation of increasing amounts of crude kidney extract alone resulted in a progressive reduction in angiotensin produced. When the angtotensin curve was extrapolated to zero extract concentration, (be level of renin activity was twice as great as that found after acidification of such crude extracts. The high angiotensinase activity of the crude extract was partially inhibited by EDTA, but in the presence of the latter, diisopropylfluoropbosphate and pbenyunethanesulfonyl fluoride, alone or together, gave no added protection. The significance of the high molecular weight renin in such extracts is not clear, although it is apparent that it is not a less active precursor of renin, as has been suggested by some investigators.
SINCE THE original observation by Lumbers' that renin
in amniotic fluid is activated by acidification, and Rubin's account of similar activation in extracts of lyophilized hog kidney, 2 there have been a number of reports of renin activation in amniotic fluids, 3 "* kidney extracts,*" 9 uterus, 10 and plasma. 1 -•'• 5 ' "~1 7 In several cases, it was determined that the renin which underwent activation had a molecular weight higher than normal. 6^'1017 Day et al.* reported that both of two samples of amniotic fluid they investigated by gel filtration had high molecular weight renin, although they found varying amounts of inactive high molecular weight renin in the plasma of only 11 of 28 patients tested, and none at all in normal control subjects. However, Skinner et a\. 4 found that inactive renin in the plasma of all their patients and normal control subjects was activated by acidification, and Derkx et al. 1 * and Boyd 16 reported similar findings for almost all of their patients. Boyd also noted that the molecular weight of
